WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹984 Cr | ₹423 Cr | ₹-718 Cr | ₹-1,521 Cr | ₹-762 Cr |
What is the latest Net Current Assets ratio of WOCKHARDT ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹984 Cr |
| Mar2025 | ₹423 Cr |
| Mar2024 | ₹-718 Cr |
| Mar2023 | ₹-1,521 Cr |
| Mar2022 | ₹-762 Cr |
How is Net Current Assets of WOCKHARDT Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹984 Cr | 132.62 | |
| Mar2025 | ₹423 Cr | Positive | |
| Mar2024 | ₹-718 Cr | Negative | |
| Mar2023 | ₹-1,521 Cr | Negative | |
| Mar2022 | ₹-762 Cr | - | |
Compare Net Current Assets of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹29,270.3 Cr | -7.6% | -17.6% | 36.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -7.6% |
-17.6% |
36.7% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses